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Abstract
Genetic studies indicate high number of potential factors related to asthma. Based on earlier linkage analyses we selected
the 11q13 and 14q22 asthma susceptibility regions, for which we designed a partial genome screening study using 145
SNPs in 1201 individuals (436 asthmatic children and 765 controls). The results were evaluated with traditional frequentist
methods and we applied a new statistical method, called Bayesian network based Bayesian multilevel analysis of relevance
(BN-BMLA). This method uses Bayesian network representation to provide detailed characterization of the relevance of
factors, such as joint significance, the type of dependency, and multi-target aspects. We estimated posteriors for these
relations within the Bayesian statistical framework, in order to estimate the posteriors whether a variable is directly relevant
or its association is only mediated. With frequentist methods one SNP (rs3751464 in the FRMD6 gene) provided evidence
for an association with asthma (OR = 1.43(1.2–1.8); p = 361024). The possible role of the FRMD6 gene in asthma was also
confirmed in an animal model and human asthmatics. In the BN-BMLA analysis altogether 5 SNPs in 4 genes were found
relevant in connection with asthma phenotype: PRPF19 on chromosome 11, and FRMD6, PTGER2 and PTGDR on
chromosome 14. In a subsequent step a partial dataset containing rhinitis and further clinical parameters was used, which
allowed the analysis of relevance of SNPs for asthma and multiple targets. These analyses suggested that SNPs in the AHNAK
and MS4A2 genes were indirectly associated with asthma. This paper indicates that BN-BMLA explores the relevant factors
more comprehensively than traditional statistical methods and extends the scope of strong relevance based methods to
include partial relevance, global characterization of relevance and multi-target relevance.
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Introduction
Asthma is a multifactorial disease influenced by wide range of
genetic and environmental factors. Despite the numerous genetic
studies carried out to gain insight into its complexity, our
understanding of the nature and consequences of the genetic
variations remains limited. Several potentially important genomic
regions have already been identified but the causal alterations
which could be responsible for the observed linkages are
sometimes not discovered or more frequently the results of the
association studies cannot be confirmed by other studies. One of
the disputed genomic regions in asthma is the chromosome 11q13
where positive linkage to atopy was first reported by Cookson
et al. [1]. Subsequent association tests carried out on this region
revealed the importance of the genes MS4A2 (earlier FceRI-b or b
chain of the high-affinity receptor for IgE), SCGB1A1 (earlier
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uteroglobin or Clara cell secretory protein (CC16)), glutathione S-
transferase pi (GSTP1) and GPR44 (earlier CRTH2) in asthma and
asthma related phenotypes [1,2,3,4].
Another frequently investigated asthma-related genomic region
is the chromosome 14q22. Its attendance in the asthma
development has been suggested by different whole-genome
linkage studies [5]. Since then several genes have been shown to
be involved in asthma-related processes in this region. These are
genes for prostanoid transmembrane receptors, such as the
prostaglandin-D2 receptor (PTGDR), the prostaglandin-E2 recep-
tor (PTGER2) and the gene for galectin-3 (LGALS3) [6,7,8].
Despite the fact that associations of these regions and genes to
asthma phenotypes were found earlier, none of them was
confirmed subsequently by genome-wide association studies
(GWAS) and meta-analyses [9,10,11].
This frequent phenomenon of genetic association studies has
been explained by several theories, like the insufficient phenotypic
descriptors (e.g. oversimplified case-control approach), insufficient
observations (e.g. the negligence of rare genetic and epigenetic
variants), ethnic differences between the study populations,
confounding factors (population stratification and admixture),
conventional design errors (small sample size, the multiple testing
problem, small minor allele frequencies, curse of dimensionality,
bias-variance dilemma, model complexity and significance, etc.),
the inappropriate approach towards complex traits (i.e. disregard-
ing the role of high-number of weak factors, gene-gene
interactions, pathway-based interpretation), and the high redun-
dancy of predictors (e.g. the discovery of non-causal, transitively
associated descriptors) [12].
To overcome several of these limitations, probabilistic graphical
models (PGMs) were proposed. Thanks to their ability to
efficiently and accurately represent complex networks, PGMs
represent powerful tools to dissect the genetic susceptibility of
complex diseases. Bayesian networks are a popular class of PGMs,
because they provide a clear, graphical semantics for representing
a complete dependency-independency map of the domain.
Therefore, the graphical representation presents a crucial
advantage to allow the distinction between direct (causal) and
indirect (due to LD) SNP-phenotype dependencies, thus ensuring a
precise mapping of causal mutations. Additionally, BNs have the
advantage of being able to efficiently deal with SNP–SNP
interactions impacting the phenotype, a situation that is called
epistasis.
Due to the high computational complexity and particularly
because of the high sample (statistical) complexity, the learning of
complete Bayesian network models is computationally prohibitive.
To cope with complexity several ‘local’ approaches have emerged
which limit their scope, and focus on the identification of strongly
relevant variables, and possibly their interaction and causal
structure. Thus, they omit a global and detailed characterization
of relevance relations [13].
Other approaches apply a resampling scheme (i.e. bootstrap) or
the Bayesian statistical framework to cope with the relatively small
sample size, and to provide uncertainty and robustness measures
for various model properties [14,15,16]. Although these methods
have a much higher computational complexity than local causal
identification approaches, their main advantage is that the
modeling is not restricted, thus global characterization of the
dependencies in the domain is possible. In fact, these approaches
provide an overall characterization of the domain without the use
of dedicated target variables [15].
Specifically within the Bayesian statistical framework the
uncertainty of the validity of a discrete hypothesis given the
observations is expressed by a probability, which is interpreted as
an a posteriori belief in the hypothesis (e.g. above 0.5 it is more
probable than not, see [17]). On the contrary, a p-value for a
hypothesis in the frequentist approach is defined using the concept
of repeatability and used indirectly through rejection to confirm a
hypotheses.
Previously, we investigated the applicability of Bayesian
networks using the Bayesian framework to learn the relevant
variables with respect to a set of target variables. This could be
seen as the Bayesian interpretation of the feature subset selection
problem. We reported Monte Carlo methods to efficiently
estimate posteriors over structural model properties, such as
Markov blanket sets and Markov blanket graphs, which represent
the strongly relevant variables and their interactions [18]. Based
on these basic concepts we introduced a new statistical
methodology, named Bayesian network based Bayesian multilevel
analysis of relevance (BN-BMLA), which supports association
analysis by estimating posteriors of strong relevance. In the context
of genetic association studies, strongly relevant variables with
respect to a phenotype represent the genetic and phenotypic
factors that directly influence the phenotype (e.g. disease
susceptibility). Strongly relevant variables statistically isolate the
target variable from all other variables. However, the standard
concept of pairwise association is not identical with the concept of
strong relevance. First, if the dependency of a SNP to the
phenotype is indirect due to LD with the causal SNP, then it is
(transitively) associated but not strongly relevant to the phenotype.
Second, if a SNP has no main effect on the phenotype, but has an
epistatic effect along with an other factor, then this SNP is not
associated (according to the prevailing terminology), but strongly
relevant to the phenotype (i.e. it is in pure interaction with the
phenotype). Therefore, strong relevance indicates either a strong,
direct association or a pure interactionist relevance. See Figure S1
for further comparison of the concept of association and strong
relevance.
Additionally, posteriors for strong relevance and partial strong
relevance for subsets of variables can also be computed. The
concept of partial strong relevance, that a set of k predictors are
strongly relevant, is particularly useful, because it defines a
hierarchical, embedded hypotheses space with varying complexity.
For a given domain and sample size the posteriors over k-(strong)-
relevance can be used to determine the sufficiency of the data and
these posteriors can also be used to investigate statistical
interactions [19]. These model properties with varying complex-
ities support the overview, the post hoc interpretation, and the
offline meta-analysis of weakly significant results [20]. We tested
the BN-BMLA method in a case-control setup using artificial
datasets for identifying interactions and conditional relevance and
it was proven to be superior over other multivariate methods using
conditional models designed to detect associations between
genotypic variables and the target variable [21].
In this paper we report results of the BN-BMLA statistical
method on real-world genotype data from our partial genome
screenings of the 11q13 and 14q22 regions in asthmatic patients
and controls. We apply and demonstrate the unique ability of BN-
BMLA to provide (1) a complete overview about partial
multivariate relevance (i.e., posteriors of partial relevance of k
predictors for varying k), (2) an overview about various types of
dependencies between a predictor and a target based on global
characterization (i.e., posteriors that a predictor is directly or
transitively dependent, or is in pure interaction), and (3) a joint
characterization of relevance for multiple target variables (i.e. to
model the dependencies of the targets). We compare these results
with results from traditional frequentist methods, and discuss the
relevant candidate genes and their interactions from the aspect of
Bayesian Analysis in Asthma Genomics
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association with asthma in our population. Among the newly
identified genes FRMD6 showed the strongest association with
asthma, and we confirmed the possible role of this gene in the
disease in an animal model and in human asthmatics.
Methods
Subjects
The study population comprised 1201 unrelated individuals of
Hungarian (Caucasian) population. Approximately, 5% of tested
subjects were probably of Gypsy origin (estimation based on state
population statistics).
Four hundred and thirty six asthmatic children, age 3–18 were
recruited to the study. All the asthmatic children had specialist
physician-diagnosed asthma with the following characteristics: (1)
recurrent breathlessness and expiratory dyspnea requiring treat-
ment; (2) physician diagnosed wheeze; (3) reversibility of the
wheezing and dyspnea by bronchodilator treatment measured as
forced expiratory volume 1 s (FEV1) by a spirometer. All the
asthmatics (or their parents) were instructed to record their
symptoms accurately for 2 weeks, the treatment, and the peak
expiratory flow (PEF) twice daily (in the evening and in the
morning). PEF 100% was determined by calculation from the
personal best value and the expected value according to the height
of the patient.
If the patient is younger than 5 years old, the determination of
lung function tests (PEF or FEV1) is usually not possible. In that
case the diagnosis and classification of the disease were made
according to the frequency and severity of other symptoms.
The treatment of the patients remained unchanged before the
blood was drawn. None of the asthmatic had experienced an
exacerbation or a respiratory infection for at least 4 weeks as
indicated by increased symptoms.
The control children were randomly selected from outpatients
from the Orthopaedic Department in the Budai Children’s
Hospital and from the Urological Department of Heim Pal
Hospital, Budapest. Children in the control group had mild
musculoskeletal alterations (like pes planus or scoliosis), phimosis,
or other small urogenital problems, showed no symptoms of
asthma and required no medication. The adult controls were
blood donors without asthma, and according to questionnaires
they had not experienced asthma symptoms earlier. The control
group comprised 765 subjects (mean age: 19612 years, 405
males/360 females).
In this paper we also demonstrate the ability of the BN-BMLA
method to predict various types of dependencies from small
amount of available data. For this purpose we applied the method
to three embedded datasets: (1) the asthma status was known in all
cases (1201 subjects, ‘‘A’’ dataset); (2) in all asthmatics (436) and in
664 controls, altogether in 1100 cases the status of rhinitis was also
known (‘‘RA’’ dataset). Rhinitis was diagnosed in 278 asthmatics
(64.0%), and in 233 controls (35.1%). Rhinitis was defined by
troublesome sneezing or blocked or runny nose severely affecting
the well being of the patient in periods without common cold or
flu. Only those subjects were involved in this dataset whose rhinitis
status was verified by specialists; (3) in 200 children (106 asthmatics
and 94 controls) the status of rhinitis and the serum levels of total
IgE and eosinophil were known (‘‘CLI’’ dataset, Table 1).
For the measurement of gene expression level in induced
sputum, 31 adults between 19 to 61 years old were enrolled in the
study, but 10 of them were excluded from the analysis because the
qualities of the sputum samples were not appropriate. The study
population comprised of 12 asthmatic patients (5 males and 7
females; mean age 36.3613.0 years) and 9 controls (4 males and 5
females; mean age 29.364.9 years). The 12 asthmatic patients had
mild atopic stable asthma, no other lung diseases and no lower
respiratory tract infection. Patients were required to have FEV1 of
greater than 70% of predicted, baseline methacholine PC20 (the
provocative concentration of methacholine causing a 20% fall in
FEV1) of less than 16 mg/ml. The 9 healthy volunteers were
recruited from the staff and students of the participating
Hungarian universities. They gave no history of respiratory
diseases, had a FEV1/FVC.80% and normal methacholine
airway responsiveness (PC20.16 mg/ml).The included groups
did not differ statistically regarding age, sex, smoking status and
allergy.
The study was conducted according to the principles expressed
in the Declaration of Helsinki, and approved by the Ethics
Committee of the Hungarian Medical Research Council (ETT
TUKEB; http://www.ett.hu/tukeb/tukeb.htm). Written informed
consent was obtained from all patients or from the parents or
guardians of the minors involved in the study.
Laboratory analysis
Genomic DNA was extracted from peripheral blood using DNA
blood isolation midi kit (Qiagen, Valencia, CA).
Multiplex PCR and SNP genotyping for 144 SNPs were
performed using 48- and 12plex genotyping assays on GenomeLab
SNPstream genotyping platform (Beckman Coulter Inc. Fullerton,
CA) using single-base primer extension technology. In addition,
SNP rs545659 was genotyped using TaqMan SNP Genotyping
Assay (Applied Biosystems, Warrington, UK) on an Applied
Biosystems 7900 Real Time PCR System as per instructions of the
manufacturer. Some samples were genotyped in duplicate in the
same and in different plates. Only those SNPs where the
genotyping call rate was .90% were included in the analysis.
Some SNPs genotyped on GenomeLab SNPstream genotyping
platform were also genotyped using TaqMan SNP Genotyping
Assays. No difference between the results of the two methods was
revealed.
Total serum IgE levels were determined by 3gAllergy blood tests
in Immulite 2000 Immunoassay System (Siemens Healthcare
Diagnostics; Deerfield, IL USA).
The eosinophil cell counts were measured by Coulter MAXM
Analyser.
RNA was isolated with the Qiagen Mini RNeasy kit (Maryland,
USA). RNA was transcribed to cDNA with the High Capacity
cDNA Reverse Transcription Kit (Applied Biosystems, Foster
City, CA). Real-time quantitative PCR was performed for the
genes found to be relevant in asthma in our analyses (FRMD6,
PTGDR, PTGER2, MS4A2, AHNAK, PRPF19, TXNDC16) and b-
actin using an ABI 7900HT Fast Real-Time PCR System (Applied
Table 1. Some characteristics of the study subjects belonging
to the CLI dataset.
Clinical and biological characteristics Asthmatics Controls
Number 106 94
Age, years 11.566.1 13.064.2
Gender, male/female 63/43 55/39
Rhinitis (%) 66.0 31.9
Total IgE kU/l 260.46111 94.6663
Eosinophil cell count 106/ml 0.3460.25 0.1460.07
doi:10.1371/journal.pone.0033573.t001
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Biosystems, Foster City, CA) and TaqMan Gene Expression
Assays. Relative gene expression was determined by the
comparative CT method (ddCT) with b-actin as the endogenous
control.
Sputum induction and analysis
Sputum was collected from 20 asthmatic and 11 healthy
volunteers. The participants inhaled 4.5% saline solution gener-
ated by a De Vilbiss Nebulizer (Ultra-NebTm 2000 model 200HI)
for 5 minutes after pre-treatment with 400 mg of inhaled
salbutamol. Induction was performed three times and the
pulmonary function was measured each time after the sputum
induction. All portions that macroscopically appeared free of
salivary contamination were selected. Samples were diluted with
phosphate buffered saline containing 0.1% dithiotreitol (Sigma, St
Louis, MO, USA), portions were agitated with a vortex and placed
on a bench rocker for 30 minutes. Samples were filtered through a
40 mm Falcon cell strainer, and centrifuged at 1500 rpm for
10 minutes. The cell pellet was resuspended in 1 ml PBS and
viability (Trypan blue exclusion method) was determined using
Burker chamber. After differential cell count, cells were stocked on
lyses buffer at 280uC until use.
SNP selection
SNPs in chromosome region 11q12.2-q13.1 and 14q22.1-22.3
were selected using HapMap data analyzed with Haploview 4.1
(http://www.hapmap.org). Our gene coverage pipeline included
tag SNPs for all of the detected haplo blocks with minor allele
frequency .0.05 and selected at an r2 of 0.8 for the CEU
population. In addition to using LD criteria, we also added SNPs
based on spacing across the region and their estimated
functionality. In this manner we selected 145 SNPs in the given
regions of Chr 11 and Chr 14 (68 and 77 SNPs, respectively) for
genotyping. See Table S1 for detailed information on the
examined SNPs.
Statistical methods
Frequentist methods. Allele frequencies were calculated by
allele counting. Data were analyzed using MedCalc 5.0 and SPSS
11.5 programs. Hardy-Weinberg equilibrium was tested by using a
x2 goodness-of-fit test. x2 test was used to test for differences in
allele distribution between the groups. Logistic regression adjusted
for age and sex was applied to assess the effect of the genetic
background to dichotomous clinical characteristics. Confidence
intervals were calculated at the 95 percent level. Estimated
haplotype frequency was calculated by Haploview 4.1: http://
www.broad.mit.edu/mpg/haploview/. Haplotype-specific ORs
were estimated using conditional logistic regression to model the
log odds of disease as a function of the individuals’ haplotype
probabilities. Normalized gene expression levels were compared
by t-test. Power analysis was carried out by genetic power
calculator (http://pngu.mgh.harvard.edu/,purcell/gpc [22].
In order to facilitate a multivariate based frequentist analysis we
applied multivariate logistic regression and multifactor dimension-
ality reduction (MDR). MDR is a nonparametric and genetic
model-free data mining method for detecting nonlinear interac-
tions among discrete genetic and environmental variables [23].
BN-BMLA method. A Bayesian Network (BN) is a directed
acyclic graph (DAG) that represents a joint probability distribution
of a set of random variables{X1, X2, …, Xn}. These refer to the
observed or measured factors (e.g. SNPs, clinical parameters) from
a specific domain. A node of the graph represents a variable and
an edge between two nodes represents a direct dependency
between the variables.
Learning a BN structure (i.e. the dependence relations of the
variables) is finding a DAG that best describes the dataset. In most
cases, where the amount of available data is modest relative to the
number of variables there are likely to be many models that have
non-negligible posteriors. However, there might be certain
structural features, e.g. the presence of an edge, that we can
extract reliably. A central structural feature is related to the
concept of strong relevance of a single variable or a set of variables.
For the definition of Markov blanket sets (MBS), see [24], for
strong relevance, see [25], for Markov blanket membership
(MBM), see [26] and for their relation, see [27].
With Bayesian learning we can estimate the strength with which
the data indicates the presence of a certain feature by estimating its
a posteriori probability (Eq. (1)):
P(f D )~
X
G
P(GD )f (G)
where G represents a BN structure, D is the dataset, and f(G) is 1 if
the feature holds in G and 0 otherwise (for an overview, see [28].
For example, we refer to p(MBS = s|D) as the MBS posterior of s.
Bayesian learning. To calculate the first term of the
summation in Eq.(1) we use Bayes rule, and we have that
P(GD )!P(DDG)P(G):
The term P(D|G) is the marginal likelihood of the data given
structure G, and the term P(G) is the prior probability of a structure
G. We used uniform prior over structures in our experiments.
Assuming that the dataset D is complete (i.e., there are no
missing values), the variables are multinomial with a Dirichlet
parameter prior for every possible instantiations of their parents,
and the prior P(G) satisfies parameter independence, parameter
modularity, and structure modularity then the marginal likelihood
has an efficiently computable closed form [29].
Bayesian model averaging. As it is mentioned before, our
goal was to compute the posterior probability of a feature (i.e.,
Eq.(1)). Because the number of BN structures is super-exponential in
the number of random variables in the domain, exact summation of
all possible structures G is computationally intractable (see [29,30].
We used Metropolis Coupled Markov Chain Monte Carlo (MC3)
[31] methods for the approximation of Eq.(1). We defined parallel
Markov chains over the space of DAGs, whose stationary
distribution were the posterior distribution P(G|D). We then
generated samples by doing random walks in these chains, and
used them to estimate Eq. (1) (for convergence and confidence
diagnostics, see [32].
Each step in a Markov Chain corresponds to local transforma-
tions of the DAG, called operators [33,34]. Following Castello, we
used three operators: (1) adding an edge to the DAG, if it does not
violate the acyclic constraint, (2) reversing an edge, if it does not
violate the acyclic constraint and (3) removing an edge from the
DAG. The probability of the operator selection was uniform.
We ran the MCMC sampler with a burn-in period of 106 steps
and then collected 56106 samples. We restricted the space of the
possible structures limiting the number of parents per node to 8.
We computed a posteriori probabilities for structural features
summarized in Table 2.
See Figure 1 for a graphical example.
In a post-processing step, we introduced the concept of k-MBS
as the k sized subset of the strongly relevant variables [19]. The a
posteriori probability of the sub-relevance of a k-sized set s is
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p(sD )~P(MBS(Y )~sD )z
X
s5s’
P(MBS(Y )~s’D ),
where the terms are the exact MBS posterior of the set s and the
MBS posterior for all its superset.
The concept of k-MBS was motivated by the observation that
typically the most probable strongly relevant variable sets often
share a significant common part. This partial multivariate
approach provides an intermediate and scalable complexity for
the analysis. Note that the cardinality of the k-MBS features is
O(nk) and the aggregation involves optionally 2n MBS subsets,
which is limited by the number of the DAG structures visited in
the MCMC run, i.e. by the number of steps, which is typically
56106, resulting in 104 different DAGs and MBS sets.
Posterior values are between 0 and 1, where 0 indicates no
relevance, 1 indicates 100% relevance between a predictor and a
target variable. In our study we consider a variable relevant when
its posterior is greater than or equal 0.5.
Results
Frequentist analysis
From the 145 genotyped SNPs 5 SNPs were monomorphic
(MAF = 0), 5 deviated from Hardy-Weinberg equilibrium in
controls (p,0.005) and 33 had poor genotyping results (poor
genotype clusters or low call rates) and were not considered for
further analyses leaving 102 SNPs (59 in 14q22.1-22.3 and 43 in
11q12.2-q13.1) for frequentist and BN-BMLA analyses.
Table S2 shows the minor allele and genotype frequencies in
asthmatic and control patients. Table S3 presents the statistical
evaluation for association of SNPs with asthma at allele and
genotype levels.
When allele frequencies were considered, one SNP (rs3751464)
in the FRMD6 gene provided an evidence for an association with
asthma (OR = 1.43 (1.18–1.75); p = 361024). Only this SNP could
withstand the correction for multiple testing. Because 102 SNPs
were considered, the Bonferroni corrected significance level was
561024. This result is compatible with a power analysis which
showed that the power of frequentist statistical tests are less than
0.2 for OR below 1.3 at sample size of 1200 (complete dataset).
When the genotype frequencies were considered, the CC
genotype of the SNP rs17831682 provided strong evidence for an
association (P = 3.961024), indicating a recessive model. This SNP
is located in the 39 UTR of the PTGDR gene and considered as an
exonic splicing enhancer (Genecards). Haplotypes were construct-
ed from the investigated SNPs (Figure S2). The permutation based
Table 2. Structural features that indicate different dependence types between the variables.
Relation Abbreviation Graphical
Pairwise features
Direct causal relevance DCR(X,Y) There is an edge between X and Y
Transitive causal relevance TCR(X,Y) There is directed path between X and Y
Confounded relevance ConfR(X,Y) X and Y have common ancestor
Association A DCR or TCR or ConfR
Pure interactionist relevance PIR(X,Y) X and Y have common child
Strong relevance SR(X,Y) PIR or DCR
Relevance of variable sets
Strong relevance MBS(Y) The set consisting of Y’s parents, its children, and the other
parents of its children (the Markov Blanket Set of Y)
Relevance for multiple target variables
Direct relation to one or more targets EdgeToAny(X, Y) There is an edge between X and Y
Strong relevance to one or more targets SR(X, Y) There is an edge between X and Y or X and Y have common
child
doi:10.1371/journal.pone.0033573.t002
Figure 1. Illustration of different dependency types between
variables in a Bayesian Network structure. Pairwise relevance
relations: Direct causal relevance (e.g., Y1 and SNP1 have common
edge), Transitive causal relevance (e.g., there are two directed paths
between Y3 and SNP5), Confounded relevance (e.g., Y2 and SNP3 have
a common ancestor SNP1), Association (e.g., Y1 and SNP1, because
SNP1 is directly related to Y1; Y3 and SNP5, because SNP5 is transitively
related to Y3; Y2 and SNP3, because they are in a confounded relation),
Pure interactionist relevance (e.g., Y1 and SNP7 have common child),
Strong relevance (e.g., Y1 and SNP1, because SNP1 is directly related to
Y1; Y1 and SNP7, because they are in pure interaction). Relevance of
variable sets: Strong relevance (e.g., the variable set consisting of Y2’s
parents, its children, and the other parents of its children is {Y1, SNP9,
Y3, SNP7}). Relevance for multiple target variables: Strong relevance to
one or more targets (e.g., the variable set consisting of {Y1,Y2,Y3}’s
parents, its children, and the other parents of its children is {SNP1, SNP4,
SNP7, SNP9}). Red nodes: potential target variables, Green nodes: SNP
variables.
doi:10.1371/journal.pone.0033573.g001
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association test of Haploview indicated two haplotypes consisting
of two SNPs (rs3751464 and rs17666653) in the FRMD6 gene for
association with asthma. The TC haplotype increased the
susceptibility to asthma (OR = 1.41 (1.07–1.87); permutation p
value 0.048), while the CC haplotype reduced it (OR = 0.73 (0.57–
0.92); permutation p = 0.02) constructed from rs3751464 and
rs17666653, respectively. The haplotype frequencies were for TC:
0.191 and 0.251 and for CC 0.606 and 0.528, in controls and
cases, respectively. The rs17666653 is located in intron 4 of the
FRMD6 gene.
Bayesian network based Bayesian multilevel analysis of
relevance
Sufficiency of the data. In the Bayesian context we first
investigated the sufficiency of the sample size of all datasets (A:
1201, RA: 1100, CLI: 200) for performing a full-scale multivariate
analysis to identify the set of relevant variables. This confirmed the
necessity of a partial multivariate approach, because there was
neither a dominant set nor a set of highly significant sets for the A/
RA and especially not for the CLI datasets (Figure S3).
Strong univariate relevance. The most relevant SNPs and
genes (i.e. with high posteriors for strong relevance with respect to
asthma) according to the BN-BMLA are presented in Table 3. In
the last column the p values and odds ratios calculated with logistic
regression are also shown. Altogether 5 SNPs in 4 genes were
found relevant in connection with asthma phenotype: PRPF19 on
chromosome 11, and FRMD6, PTGER2 and PTGDR on
chromosome 14. The SNP rs7928208 in the gene PRPF19 is
also associated with early childhood asthma (in case of children
under 6 years).
Table 4 summarizes the posterior probability of strong
relevance for the most relevant SNPs for asthma and for multiple
targets, in case of RA and CLI data sets. By multiple targets we
mean rhinitis+asthma (RA data set) and IgE level+eosinophil
level+rhinitis+asthma (CLI data set) respectively. In case of the RA
data set two SNPs in the AHNAK gene gave the strongest
correlation with the phenotype asthma+rhinitis. Interestingly, a
SNP in the most studied gene of the 11q13 region, the MS4A2, the
gene for the high affinity IgE receptor b subunit showed an
association when the CLI data was considered.
Partial multivariate relevance. The multivariate analysis
of strong relevance (i.e. the posterior probabilities of Markov
blanket sets with asthma as a target, for details see Methods)
indicated a very flat posterior distribution. This means that there
are several possible strongly relevant sets with low posteriors
instead of a dominant set with a high posterior. On the other
hand, the aggregation of the multivariate results into univariate
conclusions, i.e. strong univariate relevance (described previously)
indicated that model averaging can unhinge significant results.
Furthermore, it is also possible to aggregate multivariate results
into partial multivariate results (i.e. k-sized subsets, as detailed in
the Methods section),
This allows the investigation of SNP-SNP interactions, because
a subset with a high posterior can indicate that these SNPs have a
joint effect on the susceptibility of asthma (for a detailed
investigation of interactions, see [19]. Results for partial relevance
are systematically presented in Figure 2 showing the highest
posteriors for various subset sizes (k). In this case the ‘‘A’’ dataset
was evaluated using asthma as a target variable. The high
posteriors for k= 1,2,3,4 indicate that the data is sufficient to infer
that these variables are jointly strongly relevant, but above that
level (k$5) as shown in Figure S4 the multivariate results are
weakly significant.
We applied the MDR method on the ‘‘A’’ dataset for model
sizes (k = 1,2,3,4) using an exhaustive evaluation. The results
confirmed the strong significance of rs3751464 of FRMD6,
because it was the most frequent part of the models. However,
the difference in model scores within a certain model size was low.
The range of scores for the 20 highest scoring models containing 1,
2, 3, and 4 variables were 0.548–0.521, 0.561–0.556, 0.592–0.586,
and 0.639–0.630 respectively. Furthermore, the 20 highest scoring
models of each size (1–4) contained 51 different SNPs altogether,
which also confirms the low power of MDR in case of this data set.
In contrast to the approach followed in BN-BMLA, model
averaging was not possible because of the frequentist nature of the
MDR score (compare with Eq.1.). Manual investigation of MDR
results indicated that the following SNPs were often parts of the
highly significant models: rs3751464 in FRMD6, rs17831675 and
rs17831682 in PTGDR, rs708502 and rs708486 in PTGER2.
We also performed logistic regression analysis on the ‘‘A’’ data
set with SPSS using PIN = 0.05 as the probability threshold for
variable entry, and POUT = 0.1 as the threshold of removing a
variable from the model. The forward variable selection method
confirmed the strong significance of rs3751464 in FRMD6
(exp(B) = 1.51, C.I. 95%: [1.23–1.86], p-value,0.001) and
rs7928208 in PRPF19 (exp(B) = 0.56, C.I. 95%: [0.33–0.92], p-
value = 0.024). The logistic regression with backward variable
selection method was also applied for the 10 most significant
variables and their interactions indicated by BN-BMLA. It
confirmed the strong significance of rs3751464 (FRMD6),
rs708502 (PTGER2), and rs7928208 (PRPF19) and their interac-
tions (see detailed analysis in Gene-gene interactions Section).
Gene-gene interactions. The k-MBS concept from BN-
BMLA represents the joint relevance of k variables. However,
their effects can be linear or non-linear at some scale, which
is indicated by the absence or presence of interaction terms
in appropriate statistical models. Furthermore, (non-linear)
Table 3. Properties of the most relevant SNPs including posteriors for strong relevance with respect to asthma.
SNP Gene Influenced trait Localization Posterior probability* OR (95%CI) P-value
rs7928208 PRPF19 asthma 11q12.2 0.73 1.78 (1.08–2.95) 0.02
rs3751464 FRMD6 asthma 14q22.1 0.86 1.43 (1.18–1.75) 0.0003
rs17831682 PTGDR asthma 14q22.1 0.51 1.38 (1.00–1.80) 0.05
rs708502 PTGER2 asthma 14q22 0.85 0.98 (0.77–1.25) 0.9
rs17197 PTGER2 asthma 14q22 0.82 1.05 (0.82–1.33) 0.7
rs7928208 PRPF19 asthma at 6 years 11q12.2 0.91 4.38 (1.89–10.14) 0.0005
*Strong relevance.
doi:10.1371/journal.pone.0033573.t003
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interactions can be epistatic, i.e. a SNP has no main effect on the
phenotype, but has an effect along with an other factor. As can be
seen in the last column of Table 3, the distribution of the two SNPs
in the PTGER2 gene does not differ between the asthmatic and
control groups. It implies that these SNPs do not influence asthma
risk alone, only in interaction with other variables, in this case with
other SNPs. Table 5 presents the most probable gene-gene (SNP-
SNP) joint relevances and interactions for asthma as a target
variable. In this evaluation significant interactions between 2 and 3
SNPs were revealed. The table shows the p-values and the
Figure 2. The most probable univariate (MBM), bivariate (2-MBS), trivariate (3-MBS) subsets of variables (Asthma dataset). Relevant
SNPs having high or moderately high posteriors, i.e. high probability of being a member of the Markov blanket (MBM) of the target variable Asthma
(A). Relevant SNP sets of size 2 (B); and of size 3 (C) indicating partial strong relevance. 2-MBS and 3-MBS denote the k = 2 and k = 3 sized subsets of
Markov blanket sets. A high k-MBS posterior of a set of SNPs indicates their joint relevance and possible interactions between the SNPs.
doi:10.1371/journal.pone.0033573.g002
Table 4. The posterior probability of strong relevance for the most relevant SNPs in case of RA and CLI data.
RA* CLI**
Gene SNP Asthma Multitarget Asthma Multitarget
AHNAK rs11231128 0.801 0.826 0.394 0.684
AHNAK rs11827029 0.798 0.810 0.426 0.774
FRMD6 rs3751464 0.324 0.280 0.039 0.267
MS4A2 rs569108 0.098 0.151 0.441 0.787
PRPF19 rs7928208 0.801 0.781 0.145 0.449
PTGDR rs17831675 0.371 0.365 0.424 0.669
PTGDR rs17831682 0.542 0.598 0.466 0.703
PTGER2 rs12587410 0.367 0.348 0.772 0.922
PTGER2 rs17197 0.380 0.371 0.596 0.881
PTGER2 rs708498 0.248 0.206 0.557 0.688
TXNDC16 rs1565970 0.754 0.717 0.235 0.484
*RA – Asthma: RA dataset, Asthma as target.
RA – Multitarget: RA dataset, Asthma and Rhinitis as targets.
**CLI – Asthma: CLI dataset, Asthma as target.
CLI – Multitarget: CLI dataset, IgE level-Eosinophil level-Rhinitis-Asthma as targets.
doi:10.1371/journal.pone.0033573.t004
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corresponding odds ratios for the interaction terms in logistic
regression calculated with SPSS using the enter method. The most
relevant interactions include intrachromosomal (e.g. rs708502 in
PTGER2 and rs3751464 in FRMD6) and interchromosomal
interactions: rs7928208 in PRPF19 (chr. 11) with rs708502 in
PTGER2 (chr. 14) and rs7928208 in PRPF19 (chr. 11) with
rs3751464 in FRMD6 (chr. 14). Interestingly, the joint interaction
of these three variables is also significant (exp(B) = 0.72, C.I. 95%:
[0.58–0.89], p-value = 0.002) which is indicated by the logistic
regression backward method (described in the previous section).
According to these results, the most significant SNP in this study is
the rs3751464 in the FRMD6 gene. It influences the asthma risk
both alone and in interactions with other SNPs in PRPF19 and
PTGER2 genes. In all the interactions with the minor rs3751464
TT genotype significantly increase the asthma risk, while
interactions with the more frequent CC genotype decrease the
asthma risk (data not shown).
Detailed characterization of association relations. The
association of a genetic variant to a phenotypic feature can have
multiple types. First, because of the dependency of the genetic
factors (due to linkage disequilibrium or evolutionary patterns), the
markers typically found in genetic association studies are rarely
directly associated to the phenotype. In these cases, the association
is transitive, i.e. it is mediated by the causal SNP. For example, in
case of PTGDR, the posterior of association of the SNPs
(rs17831675, rs17831682, and rs803012) to asthma are larger
than 0.9, but rs803012 can be excluded as strongly relevant,
because its posterior of strong relevance is lower than 0.005, which
indicates its non-causal, non-functional role. Second, in case of
multiple targets, which originate potentially from a complex
dependency model, the association can be mediated by phenotypic
variables. For example in case of the asthma a possible
dependency model is shown in Figure 3, in which a SNP
affecting IgE might be both directly and transitively associated
with asthma.
To evaluate the global characterization of association types
shown in Table 2, we computed the a posteriori probability
Table 5. Gene-gene (SNP-SNP) joint relevance and interactions for asthma susceptibility.
# Genes SNPs * Posterior probability** p-value*** exp(B) (95%CI)***
1 PTGER2 rs17197 0.81 0.134 1.51 (0.88–2.59)
PTGER2 rs708502
2 FRMD6 rs3751464 0.80 0.00377 0.55 (0.36–0.82)
PTGER2 rs708502
3 PTGER2 rs17197 0.79 0.012 1.68 (1.12–2.5)
FRMD6 rs3751464
4 PRPF19 rs7928208 0.61 0.00067 1.19 (1.08–1.32)
FRMD6 rs3751464
5 PRPF19 rs7928208 0.59 0.0049 0.2 (0.07–0.62)
PTGER2 rs708502
6 PRPF19 rs7928208 0.58 0.038 3.1 (1.06–9.05)
PTGER2 rs17197
7 PTGER2 rs17197 0.78 0.0166 0.62 (0.42–0.92)
FRMD6 rs3751464
PTGER2 rs708502
8 PRPF19 rs7928208 0.58 0.256 1.16 (0.89–1.5)
PTGER2 rs17197
PTGER2 rs708502
9 PRPF19 rs7928208 0.56 0.0012 0.71 (0.57–0.87)
FRMD6 rs3751464
PTGER2 rs708502
10 PRPF19 rs7928208 0.55 0.018 1.26 (1.04–1.53)
PTGER2 rs17197
FRMD6 rs3751464
*Interaction terms were forced into logistic regression using the enter method. The main effects entered are indicated with underscore.
**Posterior probability of joint relevance.
***P-value and exp(B) values corresponding to the interaction terms in logistic regression using continuous variables.
doi:10.1371/journal.pone.0033573.t005
Figure 3. A possible dependency model in asthma. An example
for a possible transitive association between IgE and Asthma. Although
there is a possible direct relationship, IgE level may relate to asthma
indirectly via eosinophil or a presence of allergy.
doi:10.1371/journal.pone.0033573.g003
Bayesian Analysis in Asthma Genomics
PLoS ONE | www.plosone.org 8 March 2012 | Volume 7 | Issue 3 | e33573
whether a variable is directly relevant or its association is only
mediated in cases where the rhinitis status was known (RA dataset;
Table 6). Additionally, we computed whether a variable is in pure
interaction or its association is pure confounded.
Here we present some examples how the results in Table 6 can
be interpreted. The posterior that rs7928208 (PRPF19) is
transitively associated to asthma is 0.822, and the posterior for a
‘‘direct’’ relation, which is not blocked by any other variable, is
similarly high (0.718; RA dataset, asthma as a target variable). On
the contrary, the posterior that, rs569108 in MS4A2 is transitively
associated with asthma is 0.633, but the posterior for a ‘‘direct’’
relation is only 0.087. Another interesting example is rs11231128
in AHNAK. The posterior that it is transitively associated with
asthma is 0.535, the posterior that it is strongly relevant is 0.736,
and the posterior for a ‘‘direct’’ relation is only 0.029, The higher
probability of strong relevance compared to the posterior for a
transitive relation indicates a pure interaction (0.708), which
suggests that this SNP is relevant only if the rhinitis status is
known. Furthermore, when rhinitis status was excluded from the
data set the strong relevance of rs11231128 for asthma vanished
(data not shown). This shows that this SNP is strongly relevant
through interaction with rhinitis.
Association to multiple targets. To decompose the
relevance of genetic factors for various phenotypes we computed
and compared the posteriors for the strongly relevant variables
with respect to each target variable, namely IgE, and eosinophil
levels, rhinitis and asthma (CLI dataset), which participate in a
complex causal model with multiple paths. Posteriors of the
decomposed relevance for multiple target variables are presented
in Table 7.
We would like to demonstrate how the results in Table 7 can be
interpreted through an example. Following the earlier discussion
of rs569108 in MS4A2, the results on the CLI data indicate that
this SNP is strongly relevant to some of the CLI targets with a
posterior of 0.77. In case of rs708498 in PTGER2 the difference
between the posteriors is more significant. The posteriors for
strong relevance with respect to IgE, eosinophil level, rhinitis and
asthma is 0.09, 0.04, 0.05,0.61, which clearly indicates that a
relationship between rs708498 and asthma is more probable than
a relationship with any other targets. Furthermore, the posterior
probability that rs708498 is strongly relevant exclusively to IgE,
eosinophil level, rhinitis or asthma are 0.03, 0.01,0.02, 0.50, which
shows that it is more probable that this SNP is exclusively related
to asthma than to any other phenotype. This is also supported by
the posteriors that this SNP is strongly relevant to other targets,
but not to IgE,eosinophil level, rhinitis or asthma: 0.58, 0.64, 0.62,
and 0.07, with the lowest posterior for asthma in this respect.
Finally, the posterior for rs708498 being a relevant SNP for
multiple phenotypes (0.67) is relatively close to the posterior of
strong relevance for asthma (0.61), which shows that relations to
other targets are negligible.
Figure 4 displays the posteriors for strong relevance detailed in
Table 7 providing an overall view on strong relevance with respect
to the targets in CLI data set on the level of genes. It indicates that
PTGER2 (rs12587410, rs17197, rs1254600, rs708498) is related to
asthma with a higher probability, whereas PTGDR (rs17831682,
rs17831675, rs17125273) is slightly more relevant with respect to
IgE levels, though the difference between posteriors for strong
relevance of different targets is lower in the latter case.
The fact that the average posterior for strong relevance in case
of the most relevant SNPs is moderate (in case of asthma as a
target) or low (in case of IgE, eosinophil and rhintis) indicates that
the CLI data set is at its limit in terms of data sufficiency. In fact,
this resembles the flat posterior case mentioned previously.
However, even in this case, the results provided by the BN-
BMLA method at least allow a restricted analysis of the domain.
Furthermore, in case of multiple targets, the joint strong relevance
(multi-target relevance) approach provides a more robust poste-
rior.
Figure 4 also shows the relationship between the strong multi-
target relevance and its approximation based on single target
posteriors. The former accounts for the interdependencies
between targets, while the approximation treats the targets as
independent factors. Therefore, in domains that contain a
complex dependency model, the multi-target approach is more
viable, since the assumption of independency will not hold. Thus
the approximation for a joint relevance based on independently
treated posteriors of targets will yield inaccurate results.
Table 6. The a posteriori probability that a SNP is directly relevant (D-Relevant), associated, strongly relevant (S-Relevant),
transitive or in pure interaction with asthma using the RA data set.
GENE SNP Associated D-Relevant S-Relevant Interaction Transitive
AHNAK rs11231128 0.643 0.029 0.736 0.708 0.535
AHNAK rs11827029 0.868 0.021 0.728 0.707 0.399
FRMD6 rs3751464 0.862 0.284 0.300 0.016 0.331
MS4A2 rs569108 0.653 0.087 0.111 0.024 0.633
PRPF19 rs7928208 0.878 0.718 0.843 0.125 0.822
PTGDR rs17831675 0.923 0.326 0.362 0.035 0.747
PTGDR rs17831682 0.923 0.524 0.578 0.000 0.863
PTGDR rs803012 0.973 0.000 0.002 0.002 0.539
PTGER2 rs1254600 0.970 0.088 0.090 0.000 0.353
PTGER2 rs1254601 0.989 0.013 0.046 0.033 0.126
PTGER2 rs12587410 0.618 0.157 0.405 0.248 0.522
PTGER2 rs17197 0.970 0.350 0.354 0.004 0.604
PTGER2 rs708498 0.983 0.002 0.227 0.225 0.108
TXNDC16 rs1565970 0.309 0.008 0.722 0.713 0.189
doi:10.1371/journal.pone.0033573.t006
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Analysis of gene expression in mice and men
Earlier we have carried out measurements of gene expression
levels by Agilent Whole Mouse Genome Oligo Microarray
4644 K chips in the lungs of mice with allergic airway
inflammation and control mice (GSE11911 record number in
GEO database) [35]. All of the genes found to be relevant in the
present study were expressed in the lung of the mice. We
compared the expression level of the genes in the lungs of mice
with OVA-induced allergic airway inflammation and control mice.
Altogether, 1134 transcripts showed .2.0-fold statistically signif-
icant differential expression [35], but none of the relevant genes in
this study showed this level of difference. However, in all mice with
OVA-induced experimental asthma the expression level of
FRMD6 was consequently lower (in average with 1.52 fold). From
Table 7. The posterior probability of strong relevance of predictors for each target and for a multi-target case based on the CLI
data set.
Exist Only Other than
GENE SNP IgE Eos Rhi Ast AP IgE Eos Rhi Ast IgE Eos Rhi Ast MT
PTGER2 rs1254600 0.08 0.12 0.15 0.31 0.52 0.04 0.07 0.08 0.21 0.44 0.40 0.38 0.21 0.46
PTGER2 rs12587410 0.31 0.38 0.53 0.81 0.96 0.02 0.02 0.04 0.16 0.65 0.58 0.43 0.15 0.91
PTGER2 rs17197 0.08 0.17 0.22 0.73 0.84 0.01 0.03 0.05 0.43 0.76 0.67 0.62 0.11 0.85
PTGER2 rs708498 0.09 0.04 0.05 0.61 0.68 0.03 0.01 0.02 0.50 0.59 0.64 0.62 0.07 0.67
PTGDR rs17125273 0.17 0.13 0.15 0.10 0.45 0.12 0.08 0.10 0.06 0.27 0.32 0.30 0.35 0.31
PTGDR rs17831675 0.52 0.41 0.48 0.44 0.92 0.09 0.06 0.08 0.06 0.40 0.51 0.44 0.48 0.66
PTGDR rs17831682 0.59 0.53 0.53 0.53 0.96 0.06 0.05 0.05 0.05 0.37 0.43 0.42 0.43 0.71
MS4A2 rs569108 0.31 0.47 0.37 0.43 0.87 0.06 0.12 0.08 0.10 0.56 0.40 0.50 0.44 0.77
Target variables: IgE level - IgE, Eosinophil level – Eos, Rhinitis – Rhi, Asthma – Ast.
‘‘Exist’’ denotes the probability of strong relevance with respect to a given target.
‘‘Only’’ denotes posteriors for strong relevance to exactly one of the targets.
‘‘OtherThan’’denotes posteriors for strong relevance to any other target than the one specified by the subcolumn.
‘‘AP’’ column contains an approximation of multi-target strong relevance based on the individual strong relevance posteriors of the targets.
‘‘MT’’ denotes the posterior of multi-target strong relevance.
doi:10.1371/journal.pone.0033573.t007
Figure 4. The posterior probability of strong relevance of predictors for each target and for a multi-target case based on the CLI
data set. Posterior probabilities for strong relevance to Asthma, Rhinitis, Eosinophil and IgE level are indicated by different columns. Posteriors of
joint strong relevance, i.e. multi-target relevance and its approximation based on the individual posteriors for strong relevance with respect to
Asthma, Rhinitis, Eosinophil and IgE level are denoted by orange and blue curves, respectively. The approximation assumes independence between
the targets, whereas the multi-target posterior accounts for the possible dependencies between the targets.
doi:10.1371/journal.pone.0033573.g004
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the relevant genes in the present study no other genes showed such
a consequent correlation.
Next, we studied the changes in the expression levels of genes in
the known pathway involving FRMD6. The FRMD6 is part of the
conserved Hippo pathway playing a critical role in controlling
organ size by regulating both cell proliferation and apoptosis [36]
(Figure 5). One of the best known target genes of this pathway is
the antiapoptotic Birc5 [37,38] (also known as survivin) whose
expression level showed 5.94 fold increase (corrected P = 0.001) in
the lung of OVA induced mice.
We compared the gene expression levels of genes found to be
relevant in asthma in the SNP analysis in sputum samples of 12
asthmatics and 9 controls using TaqMan Gene Expression Assays
(FRMD6, PTGDR, PTGER2, MS4A2, AHNAK, PRPF19, TXNDC16).
Sputum mRNA level of FRMD6 was significantly lower in the
asthmatic patients compared to healthy controls with a fold change
of 2.73 (p = 1026). No other gene showed statistically significant
difference in this comparison.
Discussion
In this paper we presented the results of a partial genome
screening in asthma evaluated by several statistical methods. In
11q12.2-q13.1 and 14q22.1-22.3 genome regions, which were
earlier identified as asthma susceptibility regions, we successfully
genotyped 102 SNPs in 57 genes. Earlier, in different association
studies several asthma genes were identified in these regions, but
none of them were confirmed later by GWAS, although two of
them (PTGDR and GSTP1) were verified in candidate gene
association studies in several independent populations [9].
Additionally, in a study where the results of GWAS were
combined with a candidate gene approach, polymorphisms in
GSTP1 also showed an effect on asthma susceptibility [9]. In our
present study, using the BN-BMLA method, several earlier results
were confirmed. Associations were confirmed between SNPs in
PTGDR, PTGER2, MS4A2 and asthma. Interestingly, however, the
frequentist method could only identify the association of the
PTGDR gene, and was unable to detect it in the case of the other
two genes. The explanation for this phenomenon is, that according
to our evaluation, SNPs in the PTGER2 influence asthma
susceptibility in interactions or indirectly, and similarly, the
association between a SNP in MS4A2 and asthma is transitive,
which is hard to detect with traditional frequentist methods. This
might be one explanation why the association of the polymor-
phisms in this gene, which is otherwise a very plausible gene in
asthma and atopic diseases, could not be confirmed in the majority
of the studies using traditional statistical methods [39,40,41].
MS4A2 gene (earlier known as FceRI-b), which codes for the
high affinity IgE receptor b subunit has a central role in mast cell
degranulation and IgE mediated allergy.
The rs569108 SNP, which corresponds to the E237G amino
acid substitution, is predicted to introduce a hydrophobicity
change within the C-terminus of the receptor. It is adjacent to the
immunoreceptor tyrosine activation motif, and may affect the
intracellular signaling capacity of the receptor. The MS4A2 was
one of the first candidate genes in atopic diseases, and already in
1996 associations were found between E237G and significantly
elevated skin test responses to different allergens and bronchial
reactivity to methacholine in a UK population [42]. Since then,
several studies in different populations have investigated the role of
this polymorphism in asthma and atopy with very controversial
results. In this study we could not confirm a direct association
between E237G and asthma, but found a transitive association
only when each target variable, namely IgE, and eosinophil levels,
rhinitis and asthma (CLI dataset) were considered, which
corresponded to a complex model with multiple paths.
It is well documented that, in asthmatics, prostaglandin D2
modulates the physiology of the airways by causing bronchocon-
striction, vasodilation, and increase in capillary permeability and
mucus production. Mice, lacking PTGDR fail to develop bronchial
hyperresponsiveness upon ovalbumin challenge, suggesting that
this receptor has an important role in the disease [43].
Polymorphisms in the gene have been reported to be associated
with asthma in American, European and Japanese populations,
but not in Chinese children, Latinos or Koreans [44]. In our study
on Hungarian children, several SNPs showed different types of
associations (direct or transitive). Interestingly, three SNPs
(rs17831682, rs17831675, rs17125273) were slightly more relevant
with respect to IgE levels, than asthma or other targets.
Prostaglandin E2 exerts anti-inflammatory and bronchoprotec-
tive mechanisms in asthma, it inhibits the chemotaxis of
eosinophils toward eotaxin, prostaglandin D2 and C5a [45].
Polymorphisms in its receptor PTGER2 were mainly found to be
associated with aspirin-intolerant asthma, but in some studies also
with asthma in general [46]. In our study the distribution of the
SNPs in the PTGER2 gene did not differ between the asthmatic
and control groups. But, when SNP-SNP interactions were
calculated, polymorphisms of the PTGER2 participated in each
significant association. This implies that these SNPs do not
influence asthma risk alone, but in interaction with other SNPs.
When multiple targets were considered the SNPs of this gene
showed relevance only to asthma and the relations to other targets
(IgE and eosinophil levels or rhinitis) were negligible.
Besides confirming previous results, the present study also
detected new asthma genes in these regions. The most remarkable
result of the study is the role of FRMD6 in asthma. Association
between a SNP in FRMD6 and asthma risk was identified with
both the frequentist and BN-BMLA methods. A haplotype in this
gene also influenced the disease susceptibility, and the rs3751464
Figure 5. Hypothesized connection between FRMD6 and Birc5
in the conserved Hippo pathway. Hypothetic hippo pathway
components in mammals are shown in various colors, with pointed and
blunt arrowheads indicating activating and inhibitory interactions,
respectively. The pathway regulates transcriptions of several genes,
among others that of Birc5. Based on [36,37,38]. According to this
pathway lower level of FRMD6 might be associated with higher level of
Birc5, as was found in the lung of the animal model of asthma.
doi:10.1371/journal.pone.0033573.g005
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showed an influential role in interactions with other SNPs in this
respect. Additionally, the expression level of the FRMD6 was
consistently lower in the lungs of mice with allergic airway
inflammation and it was significantly lower in human asthmatics
compared with controls. The exact function of this gene and its
possible role in asthma are unknown, but some theories can be
generated from earlier and our present data. FRMD6 (FERM
domain containing 6, earlier also EX1, or Willin) is suspected to be
an upstream component of the Hippo signaling pathway [36].
Several recent publications establish that the pathway is one major
conserved mechanism governing cell contact inhibition and organ
size control [36,37]. Clearly, even small changes in this pathway
can alter the lung morphogenesis which can lead to modified
response to environmental challenges and susceptibility to asthma.
The role of this pathway in asthma is also supported by our
findings that the expression of the antiapoptotic Birc5 (also known
as survivin), one of the best known target genes of this pathway was
drastically reduced in the lung of mice with airway inflammation.
This finding supports the theory that one of the mechanisms which
can play a role in asthma is the reduced apoptotic potential of the
airway epithelium. Studies supporting this theory showed that
after rhinovirus infections, the epithelial cells of the asthmatic
lungs were unable to enter into apoptosis with the consequence
that the replicating virus caused cytopathic cell death with
extensive virus shedding [47,48]. It can be asked, however, why
earlier GWAS were unable to detect FRMD6? The simplest
explanation is that in these studies only one SNP in the FRMD6
gene was genotyped (rs7140150), which is not in LD with
rs3751464. This supports the observation of Michel et al that
GWAS coverage is insufficient for many asthma candidate genes
[9]. In addition, these GWASs were carried out in other
populations, which could significantly influence the results.
The rs3751464 SNP localizes in the 59 untranslated region of
the FRMD6 gene on chromosome 14q22.1 at 52117892 base pair.
With in silico methods, we were unable to find out the role of this
SNP (or SNPs in LD with rs3751464) in the expression or function
of FRMD6, or in the disease. In public databases no data were
available whether this SNP or its haplotype influence the binding
of any regulator elements.
Another interesting and novel finding of this study is the indirect
but strong relevance of the SNPs in the AHNAK gene to asthma.
The SNPs in this gene influenced asthma risk in interaction with
rhinitis. AHNAK is a ubiquitous protein expressed in a variety of
cell types. In epithelial cells AHNAK is distributed mainly on the
cell membranes, suggesting its role in the formation of tight
junction. Now, it is widely accepted that impaired formation of
tight junction leads to reduced barrier function and increased
susceptibility to asthma [49,50,51]. Notably, the rs11231128 is a
missense SNP, causing a serine proline amino acid substitution at
position 3724, which might influence the 3D structure of the
protein. In addition, according to the Ingenuity database, AHNAK
interacts with several factors playing important role in the disease,
like TGFB1, EGFR, IL6 and STAT4 (Ingenuity Pathway Analysis
(IPA) 9.0 Software (Ingenuity Systems, Redwood City, CA, USA;
www.ingenuity.com)).
Similarly to the SNPs in AHNAK, a SNP in the TXNDC16 gene
also influenced asthma risk in interaction with rhinitis. Until now,
however, there has been no information about the function of this
gene in any databases.
Strong and direct association was found between rs7928208 in
the PRPF19 gene and asthma and this SNP was also associated
with asthma development before 6 years of age. Although its
possible role in asthma is unknown, the product of the gene,
similarly of some earlier found asthma genes (e.g. RAD50) plays a
role in DNA repair, thus theoretically its altered function might
influence the resistance of the cells to environmental stress
[52,53,54].
The above discussed results clearly show the several advanta-
geous features of the BN-BMLA method over the traditional
frequentist methods generally used in gene association studies. As
can be seen from the results, the advantage is not only that the BN-
BMLA can detect more relevant variables, but the Bayesian
networks offer a rich language for the detailed representation of
types of relevance, including causal, acausal, and multitarget
aspects. Additionally, Bayesian statistics offers an automated and
normative solution for the multiple hypothesis testing problem.
The computational complexity is manageable using high-through-
put and high-performance computing resources for medium sized
problems with hundreds of variables. This extends the scope of
local ‘causal’ discovery methods, and because of the direct
interpretation of Bayesian posteriors, contrary to p-values from
the frequentist approach, makes it an ideal candidate for creating
probabilistic knowledge bases to support off-line meta-analysis and
fusion of background knowledge.
We analyzed partial multivariate strong relevances, because the
Bayesian statistical framework allows the calculations of posteriors
over a wide range of hypotheses, such as strong relevance of
variables, pairs of variables, triplets of variables, etc. This shows
the advantage of the Bayesian framework, because it allows the
selection of appropriate level of complexity of hypotheses, which is
not possible in the traditional hypothesis testing approach.
Conclusion
In a partial genome screening of asthma we identified FRMD6
as a novel asthma gene. The possible role of this gene was also
confirmed in an animal model and in human asthmatics. Beside
FRMD6, using BN-BMLA method, we identified several addition-
al genes (PTGDR, PTGER2, MS4A2, AHNAK, PRPF19,
TXNDC16), which directly, or indirectly might play a role in the
disease. In contrast to BN-BMLA, the traditional and novel
frequentist based methods (x2 test, multivariate logistic regression
and multifactor dimensionality reduction) could consistently
identify only the direct effect of FRMD6 on asthma risk, and in
some models the possible effect of PTGDR, PRPF19 and PTGER2.
The BN-BMLA on one hand extends the scope of strong relevance
based methods towards (1) partial multivariate relevance, (2) global
characterization of pairwise relevances, and (3) multi-target relevanc-
es. On the other hand it can be seen as focusing the general, global
feature learning techniques towards relevance analysis, i.e. from
learning arbitrary dependency substructures to learning strongly
relevant sets. Furthermore, this Bayesian global relevance analysis
method provides posteriors, which are direct statements about
hypotheses, thus it can also be used to construct probabilistic data
analytic knowledge bases in genetic association studies to support
complex quering, off-line meta-analysis, and fusion with background
knowledge. Although, in artificial datasets we have previously
demonstrated the superior ability of the BN-BMLA method to detect
real factors and interactions in genetic association studies, the method
must be applied to other real word datasets, and the results must be
validated in alternative methods. If these studies confirm the
usefulness of this new statistical method, it could be a good alternative
to evaluate the results of gene or genome association studies.
The tool is accessible at http://webbmla.genagrid.eu.
Supporting Information
Figure S1 Comparison of standard concept of (pair-
wise) association and strong relevance. The concept of
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strong relevance and association (with respect to a target) has only
one common element, direct relevance, i.e. non-mediated
relationship between the target and a variable. Association also
includes confounded and transitive relevance, where there is a
mediator between the given variable and the target. In cause-effect
relationship terms, the confounded case corresponds to a common
cause; the transitive case corresponds to a cause- effect path.
Strong relevance, on the other hand, includes interactionist
relevance, i.e. a common effect type relationship.
(TIF)
Figure S2 Haplotype blocks of the investigated SNPs in
the present study. SNPs are numbered sequentially and their
relative location is indicated along the top. Markers 1–54 and
markers 55–102 correspond to the studied SNPs on Chromosome
14 and 11, respectively. Triangles surrounding markers represent
haplotype blocks.
(TIF)
Figure S3 The peakness of the posteriors of the most
probable 100 MBS sets. The x axis denotes the rank of a
Markov blanket set (MBS) of SNPs, the y axis denotes the joint
probability of an MBS, e.g. an MBS with rank = 5 is the fifth most
probable set. The ‘‘RA’’ and ‘‘CLI’’ prefixes denote the
corresponding dataset, and the ‘‘asthma’’ and ‘‘multitarget’’
suffixes indicate the target variables. RA- multitarget: Rhinitis,
Asthma; CLI- multitarget: Asthma, Rhinitis, Eosinophil and IgE
level. Note, that the peakness of the posteriors decreases within the
same dataset in the multitarget case; and between different data
sets, the smaller sample size (CLI:200, RA:1100) results in weaker
posteriors. In terms of data sufficiency, the flatness of the CLI
MBS posterior curve (both in the single target and the multitarget
case) indicates that the CLI data is not sufficient for a complete
multivariate analysis. The RA dataset, on the other hand, is more
appropriate having a relatively peaked posterior, although the
maximum posterior is not particularly high.
(TIF)
Figure S4 The most probable univariate (MBM), bivar-
iate (2-MBS), trivariate (3-MBS), 4-MBS, 5-MBS subsets
of variables. All posteriors of partial k-relevance are ordered, x
axis denotes the rank (e.g.: the number 2 means the second highest
posterior), and y axis denotes the posterior probabilities. As k
increases (i.e. the set size of jointly considered SNPs) the maximum
posteriors decrease, and the slope of the posteriors are much less
‘‘peaked’’, which means that the lower ranked posteriors are
significantly higher than those with higher ranks. The univariate
case can be considered as a relatively peaked curve, and as k
increases, the curve ‘‘flattens’’. The curve of whole sets (MBS) is
the ‘‘flattest’’, showing only a small difference between the lower
ranked and the higher ranked posteriors. In this case, estimating
the top 20 MBS is less informative than estimating the top 10
partial k-relevance of k = 2. This indicates the viability of the
concept of partial k-relevance.
(TIF)
Table S1 Information on the examined SNPs.
(XLS)
Table S2 Minor allele and genotype frequencies (%) in
asthmatic (n=436) and control (n= 765) patients.
(DOC)
Table S3 Statistical evaluation for association of SNPs
with asthma at allele and genotype levels.
(DOC)
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